Hepatitis B virus resistance to nucleos(t)ide analogue therapy: WHO consultation on questions, challenges, and a roadmap for the field

Lumley SF., Mokaya J., Maponga TG., Kramvis A., Dusheiko G., Irving W., Delphin M., Said Mohammed K., Downs LO., Waddilove E., Anderson M., Iwuji C., Msomi N., Ocama P., Hamid S., Adda D., Halford R., Kabagambe K., Benschop KSM., Inzaule S., Chan P., Paul MAS., Izumi K., Nisa T., De Dieu Iragena J., Girón-Callejas A., Kpossou AR., Jamiyu G., Emmanuel O., Balkissa M., Keita M., Prabdial-Sing N., Martinez A., Magongo EN., Shao Y., Sued O., Sereno LS., Shafer RW., Lesi O., Faini D., Easterbrook P., Duncombe C., Jordan MR., Matthews PC.

DOI

10.1016/j.lanmic.2025.101076

Type

Journal article

Journal

The Lancet Microbe

Publisher

Elsevier BV

Publication Date

04/2025

Pages

101076 - 101076

Permalink Original publication